Making effective PR accessible to an underserved market
Pathos Communications is a technology-enabled, human-led PR business focused on making
effective media engagement accessible and affordable for SMEs and founder-led companies.
Founded in 2019 by CEO Omar Hamdi, the company has its principal operating base in
Dubai and employs around 70 people. Pathos joined AIM in December 2025, raising £5.6m
gross at 30p per share, of which c £5.0m comprised new growth capital. The proceeds
are being invested in proprietary AI technology, additional staff and international
expansion to support scalable growth.
A fundamentally different approach to traditional PR
Pathos is targeting more than 400m SMEs and founder-led companies globally, creating
a very large but highly fragmented market that is difficult to reach and has relatively
limited spending power. Traditional PR is poorly configured for this market: retainers
are expensive, outcomes are uncertain and delivery often depends on a small number
of experienced publicists with personal media relationships. As a result, many potentially
newsworthy smaller businesses cannot access the credibility and visibility that established
media coverage can provide.
Pathos offers a fundamentally different and highly innovative alternative to the traditional
model. Its productised, predominantly pay-on-results service identifies businesses
with credible stories, helps shape and produce the content, secures suitable media
placement and supports clients in reusing that coverage across their sales and marketing
activities. Customers primarily pay once an agreed placement has been delivered, materially
reducing the cost and perceived risk of trying professional PR for the first time.
In the longer term, Pathos’s ambition extends beyond operating a more efficient alternative
to a PR agency. The company is investing in proprietary AI and workflow technology
to automate much of the activity underlying customer acquisition, content development
and account management, while retaining human involvement where judgement, trust and
publisher relationships are most important. The objective is to build a scalable global
PR platform capable of serving a large number of relatively small customers without
requiring a proportionate increase in experienced staff.
Pathos is developing technology and workflows to transform both customer acquisition
and service delivery: identifying businesses with timely stories, approaching them
with more relevant and customised propositions, and potentially producing article
concepts or initial drafts for prospects to review. Management is aiming to penetrate
less engaged parts of the SME market and, by lowering the cost to serve, develop new
offerings at different price points. The objective is therefore to accelerate market
penetration and revenue growth as well as create operational leverage, while retaining
human involvement where judgement, trust and publisher relationships are most important.
Increasing reach, relevance and efficiency across the customer journey
Pathos is applying technology across the customer journey, from identifying and converting
prospects through content production, placement and post-publication support. At the
front end, technology supports better targeting and more personalised outreach at
greater scale, increasing engagement and expanding the serviceable market. During
delivery, AI and structured workflows improve speed, consistency and capacity, enabling
customer-facing staff to focus on understanding client objectives, applying strategic
and editorial judgement and maintaining publisher relationships while serving a larger
customer base.
| Exhibit 1: Optimising and automation at each stage of the client journey |
 |
| Source: Pathos Communications |
Product development and automation central to marker development and scalable growth
The company has two key products, which are central to its scalable growth plans:
PathosMind, described by management as its ‘in-house LLM AI agent’, is the underlying intelligence
and content engine. It monitors more than 50,000 news and social media sources for
identified leads and clients, finds relevant news hooks, undertakes research and generates
article ideas and initial drafts. Its outputs are integrated into Pathos’s CRM, supporting
both sales preparation and content production.
Pressella, described as an AI ‘virtual publicist’, acts as the interaction layer. It attends
client meetings, captures and assesses the discussion, and draws on PathosMind’s intelligence
to suggest potential stories and positioning. Information gathered by Pressella can
then feed back into PathosMind’s research and drafting process, linking the client
conversation directly with content creation.
Both tools were already in internal use at the time of the December 2025 IPO, but
investment and deployment have since accelerated, supported by a dedicated development
team and CTO. Early evidence includes Pressella achieving a sales-meeting booking
seven times as high as human colleagues in a short controlled test, while both tools
benefit from learnings accumulated across more than 370,000 client and prospect conversations.
Management expects wider internal deployment to begin contributing to stronger growth
from H2, ahead of targeted general availability to clients and PR agencies in H127.
Technology and automation across the customer journey
These tools are being deployed, alongside others, at several stages of Pathos’s CRM-managed
sales and delivery process. They automate repeatable activities and improve handovers
between teams, while retaining human involvement where trust, editorial judgement,
quality control and publisher relationships are critical.
- Lead generation and conversion: Pathos sources and filters prospects from more than 20 channels. PathosMind equips sales staff with relevant news hooks, research and article ideas, while Pressella is being tested and deployed in sales development for prospect engagement, meeting
booking and call assessment. The deployment of technology is key to increase meeting
volumes and conversion while reducing acquisition costs.
- Client discovery and content production: Pressella captures and assesses the introductory client discussion, with the resulting information
feeding into PathosMind’s research and drafting process. Human staff then refine the positioning, check quality
and accuracy, and secure client approval. This should shorten turnaround times and
increase content capacity.
- Media placement: This stage is purposely more human led, to retain trusted relationships with publishers.
Pathos selects an appropriate publication based on the client’s objectives, contractual
commitment and likely impact. Experienced staff assess editorial fit and manage publisher
relationships, while publishers retain editorial control. Technology supports the
surrounding workflow, but neither AI product currently replaces human placement judgement.
The company recently entered into a strategic 24-month agreement with one of the ‘Big
Three’ US news periodicals with no minimum commitment from Pathos, while the publisher
has committed to publishing up to 2,000 articles for Pathos clients.
- Customer success and repeat engagement: Supported by a custom CRM, Pathos coordinates client requirements, timing, payments
and publication selection through structured workflows. Following publication, it
helps clients reuse their coverage and identifies further opportunities, including
articles, podcasts, television, books and Pathos Priority membership. More systematic
follow-up should increase repeat revenue, lifetime value and revenue visibility.
Financial model: New customers, repeat sales and operational leverage
Unlike traditional agencies, which generally charge retainers without guaranteeing
coverage, Pathos predominantly operates a success-based, pay-as-you-go model in which
customers pay when an agreed placement is delivered. Its service extends beyond placement
to include story identification, content development and post-publication support.
A standard written placement has historically cost c $5,000, while Pathos Priority
combines a c $1,000 annual fee with a reduced placement price of c $3,500. Established
customers may also purchase larger packages upfront.
Pathos’s large, underpenetrated market provides a high ceiling for growth, but execution
depends on identifying, converting and retaining suitable customers efficiently. High
gross margins, lower acquisition costs on repeat business and increasing automation
should also allow revenue to grow faster than the cost base. The clearest measures
of progress are:
- New customer sales: Customer numbers and sales values indicate Pathos’s ability to penetrate its fragmented
market. Meeting bookings, conversion rates and customer-acquisition costs should demonstrate
whether PathosMind and sales automation are improving targeting and productivity.
- Repeat sales: Repeat customers and revenue validate the value proposition and increase customer
lifetime value. Subsequent purchases should require less sales expenditure, while
upfront packages improve revenue visibility, cash flow and working-capital characteristics.
- Operational leverage: Successful acquisition and retention, combined with automation across sales and delivery,
should allow revenue to outpace costs. This should be reflected in revenue per employee,
adjusted EBITDA margins and cash conversion.
Encouraging progress across the KPIs since IPO
H126 trading sustained the positive trends seen in FY25, providing encouraging evidence
that Pathos is both expanding customer acquisition and increasing customer lifetime
value – the two principal drivers of scalable growth. Revenue increased by 14% to
$7.3m following 15% growth in FY25. Repeat customers generated 36% of revenue, 30%
in FY25 and 16% in H125. Meanwhile, new-client sign-ups have risen by c 30% since
the new sales-management structure was introduced, supported by PathosMind. Additionally,
a $0.7m 12-month contract, secured in May 2026, is expected to provide revenue and
EBITDA across FY26 and FY27.
Adjusted EBITDA increased by 31% to $1.7m (23% margin) despite Plc and increased investment
costs. Investment in Pressella and PathosMind is capitalised and therefore not reflected
in EBITDA, but cash performance was nevertheless encouraging. Receipts increased by
more than 80%, bad debts fell to c 4% of revenue and net cash declined by only $0.3m
to $5.9m. With the investment in the sales team and the training and deployment of
Pressella broadening, management is confident of delivering accelerated growth in
H2 and meeting market expectations. Given the progress already delivered in H1 and
the expected acceleration, we believe that there is scope for upside.
Valuation: Significant growth potential at value-stock multiples
At 27.5p, Pathos’s shares trade only modestly below the 30p IPO price, giving a market
capitalisation of c £18m and an enterprise value of c £16m based on FY25 net cash.
Current consensus forecasts imply EV/adjusted EBITDA multiples of approximately 5x
for FY26 and below 4x for FY27, alongside adjusted P/E multiples of c 10x and 9x,
respectively. These value-stock ratings give limited credit for Pathos’s large addressable
market, proprietary technology and longer-term scalability or the scope for upside
evident in the H1 trading update.
Pathos still has important milestones to deliver, including establishing a longer
listed track record and demonstrating that its technology can support growth at scale.
However, the current valuation appears to reflect much of this execution risk while
assigning little value to the potential upside. Post-IPO execution has been encouraging,
and the leading indicators are positive. Sustained growth and evidence that technology
can drive sales productivity, margin expansion and cash conversion could therefore
support a re-rating.
